Mazur Leonard L — SEC Form 4 filings
SEC reporting owner CIK 1463414. 11 Form 4 filings on record with FilingPulse; latest filed 2025-12-22.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-04-05 to 2025-12-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | Chief Executive Officer, Director | 4 | — | — | 11 |
| CITIUS ONCOLOGY, INC. (CTOR) | Chief Executive Officer, Director | 6 | — | — | 6 |
| Tharimmune, Inc. (THAR) | Director | 1 | — | — | 1 |
Form 4 filings — Mazur Leonard L
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-12-22 | 4/A | CITIUS ONCOLOGY, INC. (CTOR) | Grant/award (A): 1,700,000 @ $0 | EDGAR |
| 2025-12-01 | 4/A | CITIUS ONCOLOGY, INC. (CTOR) | Grant/award (A): 1,700,000 @ $0 | EDGAR |
| 2025-09-23 | 4 | Citius Pharmaceuticals, Inc. (CTXR) | Disposition to issuer (D): 125,490 (derivative) · Grant/award (A): 125,490 (derivative) · Disposition to issuer (D): 89,388 (derivative) · Grant/award (A): 89,388 (derivative) | EDGAR |
| 2025-09-23 | 4 | CITIUS ONCOLOGY, INC. (CTOR) | Grant/award (A): 1,700,000 @ $0 | EDGAR |
| 2024-12-16 | 4 | CITIUS ONCOLOGY, INC. (CTOR) | Grant/award (A): 800,000 (derivative) @ $0 | EDGAR |
| 2024-11-12 | 4 | Citius Pharmaceuticals, Inc. (CTXR) | Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2024-09-27 | 4 | Citius Pharmaceuticals, Inc. (CTXR) | Disposition to issuer (D): 3,137,255 (derivative) · Grant/award (A): 3,137,255 (derivative) · Disposition to issuer (D): 2,234,700 (derivative) · Grant/award (A): 2,234,700 (derivative) | EDGAR |
| 2024-08-30 | 4/A | CITIUS ONCOLOGY, INC. (CTOR) | Grant/award (A): 3,700,000 (derivative) @ $0 | EDGAR |
| 2024-08-14 | 4 | CITIUS ONCOLOGY, INC. (CTOR) | Grant/award (A): 1,233,333 (derivative) @ $0 | EDGAR |
| 2024-08-12 | 4 | Tharimmune, Inc. (THAR) | Grant/award (A): 2,353 (derivative) @ $0 | EDGAR |
| 2024-04-05 | 4 | Citius Pharmaceuticals, Inc. (CTXR) | Disposition to issuer (D): 1,165,048 (derivative) · Grant/award (A): 1,165,048 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1463414 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →